Australian Billionaires’ Sigma Healthcare In Talks To Buy U.K.’s Boots In Deal Valued At $10 Billion
Sigma said the talks are at an early stage and no transaction is certain, as Boots weighs a sale instead of a London listing.
- On Wednesday, Sigma Healthcare confirmed it is in preliminary discussions to buy UK retail chain Boots, though the company stressed there is "no certainty" any transaction will take place.
- Since merging with Chemist Warehouse Group last year, Sigma has ramped up ambitions and recently entered the British market by acquiring a 75 per cent stake in Greenlight Healthcare.
- The Canadian branch of the billionaire Weston family, which controls Loblaws, is also in talks with Boots owner Sycamore Partners, which acquired the 177-year-old retailer for $23.7 billion just last year.
- Reports suggest the deal could be worth more than $14 billion, though a private sale would deal a fresh blow to the London Stock Exchange where Sycamore is still considering an initial public offering.
- Shares of Sigma closed down about 5.5% on Wednesday amid the announcement; the company stated it "continuously reviews opportunities that would create value for shareholders," while representatives for Boots and Sycamore declined to comment.
24 Articles
24 Articles
Australian Billionaires’ Sigma Healthcare In Talks To Buy U.K.’s Boots In Deal Valued At $10 Billion
Sigma Healthcare—which counts Australian billionaire brothers Jack and Sam Gance and their business partner Mario Verrochi as its biggest shareholders—has been seeking to expand in the U.K.
Australia’s Sigma confirms talks over Boots takeover
It followed reports the Weston family is also holding discussions over a possible £7.5 billion deal.
Australia's Sigma Confirms Talks on Buying UK's Boots Chain
(Bloomberg) — The Australian owner of the Chemist Warehouse chain of pharmacies confirmed it’s one of the parties in talks to buy British drugstore chain Boots in a deal that could be worth as much as $10 billion.
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium











